this post was submitted on 16 Nov 2023
89 points (100.0% liked)
science
15017 readers
637 users here now
A community to post scientific articles, news, and civil discussion.
rule #1: be kind
<--- rules currently under construction, see current pinned post.
2024-11-11
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
This gene is already targeted by injected drugs but they are very expensive.
"PCSK9 has medical importance because it acts in lipoprotein homeostasis. Agents that block PCSK9 can lower LDL particle concentrations. The first two PCSK9 inhibitors, alirocumab and evolocumab, were approved as once every two week injections, by the U.S. Food and Drug Administration in 2015 for lowering LDL-particle concentrations when statins and other drugs were not sufficiently effective or poorly tolerated. The cost of these new medications, as of 2015, was $14,000 per year at full retail; judged of unclear cost effectiveness by some."